Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Therapure Biopharma" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Therapure Biopharma for you to read. Along with our medical data and news we also list Therapure Biopharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Therapure Biopharma Companies for you to search.
New plasma products and technology company-Evolve Biologics-led by Blaine Forshage as CEO
Evolve Biologics, the biologics division of Therapure Biopharma Inc., today announced that in February 2018 the company confidentially submitted a draft registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common shares. The initial public offering is exp...
SummaryTherapure Biopharma Inc Therapure is a biopharmaceutical company that offers research and development services. The company's activities include manufacture, development, purification, and packaging of therapeutic proteins and followon biologics. It operates through its division therapure biomanufacturing, therapure innovations and therapure biologics. Therapure's therapure biomanufacturing...
It’s not unusual for a biopharma company, given enough time, to have its ups and downs. But PDL BioPharma’s roller-coaster ride has been more dramatic than most.
KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.
In between NIBRT site tours and tax workshops in Dublin Castle, Biopharma-Reporter is covering BioPharma Ambition on the Emerald Isle.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Biopharma/Biotech .CA-South San Francisco, Biopharma/Biotech Company: Amgen, Inc. Location: South San Francisco, CA Position Type: Full Time Experience: Unspecified Education: Unspecified Amgen, Inc. has opptys in South San … Continue reading → Cet article #jobs #l...
New plasma products and technology company led by experienced senior management team, with industry veteran Blaine Forshage as Chief Executive Officer Dedicated to commercializing proprietary PlasmaCap EBA® technology to efficiently meet growing global demand for plasma-derived therapeutics Pipeline of product candidates, initially focus...
NewsPrestige BioPharma and Alvogen have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma´s Trastuzumab biosimilar in Central and Eastern Europe.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Director of Corporate Communications – Ph III Biopharma .MA-Lexington, If you are a Director of Corporate Communications with rare disease, ophthalmology, and/or nephrology experience, please read on! What … Continue reading → Cet article #jobs #lifescience D...
Tasly Biopharma paid $48 million in stock to buy out its China JV partner Transgene (P: TNG), which holds China rights to two Transgene products: T601, an oncolytic virus, and T101, a therapeutic vaccine. The stock represents 2.53% of Tasly Biopharma's capital after a pre-IPO investment round, which priced at the same time as the Transgene transaction. Tasly Biopharma, the novel drug subsidiary of...
Half of Required Infusions Now Successfully Administered in Adult Portion of Study A Prospective, Open-Label, Multicenter Study of the Efficacy, Safety, Tolerability and Pharmacokinetics of PlasmaCap IG in Adults and Children with Primary Immune Deficiency Diseases Evolve Biologics (“Evolve”), a division of Therapure Biopharma Inc. ...
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: (Senior) Manager, Regulatory Operations – Biopharma .MA-Waltham, Direct-hire opportunity for a Manager or Associate Director of Regulatory Operations! This is a newly created role with a growing biotech … Continue reading → Cet article #jobs #lifescience (Sen...
NewsThe University of Nebraska Medical Center and Hemispherx Biopharma, Inc. are joining forces to take on pancreatic cancer, one of the most deadly forms of cancer.
Launches training program for biopharma professionals
Dr. Thomas Rösch boasts over 16 years of industry experience, and will head the Biopharma Engineering & Technology unit
This specialty instrument was developed in response to the biopharma industry’s rapidly expanding requirements
PDL BioPharma today officially announced it will no longer pursue its proposed acquisition of US modified-release…
Not only are women generally underrepresented in the biopharma industry, but compared to many of the top male executives, underpaid. Here’s a closer look at the top five female executives by pay in the biopharma industry.
NewsCara Therapeutics, partnering with Enteris BioPharma, has initiated the Phase One clinical trial of its oral Korsuva in patients with chronic liver disease. Enteris will continue to manufacture the oral tablet formulation through Phase Two.
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced that the U.S. Food and Drug...
Tasly Biopharma of Shanghai raised $84.5 million in new capital from a group of investors that included Ally Bridge. The funding is a pre-IPO round as Tasly is planning to list on the Hong Kong Exchange. The investors received a 4.5% stake in Tasly Biopharma, implying a $1.9 billion pre-IPO valuation. Tasly Biopharma is a subsidiary of Tasly Pharma. As a separate part of the transaction, Transgene...
In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with William J Newell, Chief Executive Officer at Sutro Biopharma, a biopharma drug development firm They discuss the company's: • origins and business model • collaborations • platform technology, how it works and its advantages over its competitors’ platforms • plans for the future
Landos Biopharma CEO Josep-Bassaganya-Riera tells Proactive Investors the biopharma has very high expectations on how the company's drug, BT-11, will move forward. Landos began dosing the drug in Phase 1 clinical study in July, they anticipate results in November.